Porcine Circovirus 3: Veterinary Reference

1. Overview and Taxonomy of Porcine Circovirus 3: Veterinary Reference

1.1 Historical Context and Emergence

Porcine circovirus 3 (PCV3) represents a seminal addition to the Circoviridae family, first identified in 2016 in the United States through metagenomic sequencing of tissue samples from sows experiencing a profound outbreak of porcine dermatitis and nephropathy syndrome (PDNS)-like clinical signs, reproductive failure, and multisystemic inflammation [2, 9, 11]. The initial detection of PCV3, however, was far from the virus's actual emergence. Retrospective molecular epidemiological investigations have unequivocally demonstrated that PCV3 has been circulating within global swine populations for decades prior to its formal characterization. Analysis of archival samples from China traced the virus back to 1996, with 6.5% of porcine samples collected between 1990 and 1999 testing positive for PCV3 DNA [8]. Similarly, retrospective studies in the United States detected PCV3 in serum samples from grower-finisher herds as early as 2000, with farm-level prevalence reaching 47% at that time, indicating that the virus was already endemic in the US swine industry well before its first description [3]. These findings collectively underscore that PCV3 is not a truly emergent pathogen but rather a long-established, ubiquitous virus whose clinical significance has only recently been appreciated. The global distribution of PCV3 is now extensively documented across North America, South America, Europe, Asia, and, most recently, the Caribbean region, with the first report from the Dominican Republic confirming its presence in the Caribbean archipelago [4, 8, 13, 15].

1.2 Genomic Architecture and Organization

The PCV3 genome is a single-stranded, closed circular DNA molecule of approximately 2,000 nucleotides (nt) in length, making it the smallest known member of the genus Circovirus that infects swine [1, 4, 7, 13]. The compact genomic structure encodes at least three major open reading frames (ORFs), a hallmark of circoviruses. ORF1 encodes the replicase (Rep) protein, a 296-amino acid (aa) polypeptide essential for rolling-circle replication of the viral genome. The Rep protein is highly conserved among PCV3 strains and shares significant homology with the Rep proteins of other circoviruses, including porcine circovirus 2 (PCV2) and avian circoviruses. ORF2, the most genetically variable region of the genome, encodes the capsid (Cap) protein, which is the primary structural component of the virion and the principal antigenic determinant driving the host humoral immune response [1, 3, 5, 13]. The Cap protein is responsible for viral attachment, host cell tropism, and the induction of neutralizing antibodies. ORF3, located within the ORF1 region but transcribed in the opposite orientation, encodes a protein implicated in the induction of apoptosis in infected cells. This ORF3-mediated apoptosis is hypothesized to contribute to the pathogenesis of PCV3, analogous to the role of the ORF3 protein in PCV2 infection, which triggers programmed cell death through interactions with host cellular machinery and participation in multiple apoptotic signaling pathways [17]. The non-coding region of the genome contains the origin of replication, which features a conserved stem-loop structure characteristic of circoviruses, essential for the initiation of rolling-circle replication.

1.3 Taxonomic Classification and Species Definition

PCV3 is classified within the family Circoviridae, genus Circovirus. The species is officially designated as Porcine circovirus 3 by the International Committee on Taxonomy of Viruses (ICTV). The taxonomic delineation of PCV3 from other circoviruses, particularly PCV1 and PCV2, is based on robust phylogenetic analysis and sequence identity thresholds. Complete genome sequence comparisons reveal that PCV3 shares less than 70% nucleotide identity with PCV1 and PCV2, satisfying the established species demarcation criteria for circoviruses, which typically require less than 75% genome-wide nucleotide identity for classification as distinct species [1, 4, 8]. The pair-wise nucleotide sequence identity among circulating PCV3 strains is remarkably high, generally exceeding 97% at both the complete genome and ORF2 levels, indicating substantial genetic stability across temporally and geographically diverse isolates [4, 8, 9, 12]. This high level of conservation is a defining feature of PCV3 and contrasts with the more rapid evolutionary dynamics observed with PCV2, which exhibits greater genetic diversity and ongoing genotype replacement.

1.4 Genotyping Systems and Phylogenetic Clades

The genetic diversity of PCV3, while relatively constrained, has permitted the delineation of several distinct genotypes and subtypes. The most widely adopted classification scheme identifies three major genotypes: PCV3a, PCV3b, and PCV3c [1, 3, 5, 14, 15]. This genotyping framework is primarily based on phylogenetic analysis of complete genome sequences or, more commonly, the complete ORF2 (Cap) gene sequences. Early studies following the initial discovery classified circulating strains into two main clades, PCV3a and PCV3b, with subsequent surveillance leading to the recognition of PCV3c as a distinct third lineage [1, 9, 14, 15].

The PCV3a genotype is globally distributed and encompasses a substantial proportion of characterized strains. It is further subdivided into subclades, including PCV3a1, PCV3a2, and PCV3a3, which exhibit characteristic amino acid signature patterns within the Cap protein [3]. For instance, the Cap protein of PCV3a strains typically displays a distinct pattern at residues 24, 27, 77, and 150, often denoted as VKSI, which serves as a molecular marker for this genotype [14]. The PCV3b genotype, while also widely prevalent, is less frequently detected than PCV3a in many regions. Conversely, PCV3c has emerged as a dominant genotype in certain geographic areas and time periods. For example, epidemiological surveillance in Hunan Province, China, from 2021 to 2024 revealed that PCV3c was the predominant genotype, accounting for 67.6% of positive samples, followed by PCV3a (32.4%), with PCV3b entirely undetected [5]. Similarly, a comprehensive analysis of strains from Zhejiang Province, China, found that most sequences clustered within the PCV3c clade [14]. This geographic and temporal variation in genotype distribution, which may be driven by subtle differences in viral fitness, host population immunity, or selective sweeps, underscores the need for continued global surveillance.

1.5 Cap Protein as the Genotyping Target

The ORF2-encoded capsid protein is the essential target for PCV3 genotyping because of its exposed location on the virion surface, which renders it subject to selective pressure from the host immune system. Molecular characterization of the Cap protein across genotypes has identified numerous amino acid substitution sites, many of which are located within predicted B-cell linear epitopes and T-cell epitope regions [3, 5]. The mutations A24V and R27K are among the most common amino acid changes observed across PCV3 subtypes, and these residues are located within predicted antibody recognition domains, suggesting a potential role in immune evasion [3, 12]. Indeed, alterations at positions 24 and 27 have been shown to change the structural folding of the Cap protein, transitioning from an alpha-helix to a coiled conformation, which could alter antigenic presentation and binding affinity of host antibodies [3]. Additional mutations, such as S77T, F104Y, and I150L, are associated with specific subtypes. The F104Y mutation lies within a predicted T-cell epitope and is present in PCV3c, PCV3b, and PCV3a3 subtypes, but not in PCV3a1 or PCV3a2, suggesting genotype-specific immunological profiles [3]. Detailed epitope prediction and homology modeling of the PCV3 Cap protein have identified seven linear B-cell epitopes, with ten amino acid variation sites located within these epitopic regions, further emphasizing the antigenic variability of the capsid [5].

1.6 Evolutionary Dynamics and Selection Pressures

Despite its relative stability, PCV3 is subject to measurable evolutionary pressures, including both purifying (negative) and diversifying (positive) selection. Analysis of US strains from 2000 to 2012 revealed evidence of diversifying selection at specific amino acid residues of the Cap protein, most notably at positions 24, 27, and 150 [3]. The overall evolutionary rate of PCV3, however, is substantially lower than that of PCV2, contributing to the observed genetic homogeneity of PCV3 populations worldwide [6]. The epidemiological dynamics of PCV3 are further shaped by viral flow between different host populations. Phylodynamic analyses of Italian strains demonstrated a higher infection risk in wild boar and rural pigs compared to commercial pigs, with a significant directional flow of virus from wild and rural populations into intensive commercial farming systems [6]. This pattern highlights the role of non-commercial and feral swine reservoirs in sustaining PCV3 circulation and evolution, a dynamic that mirrors observations for other swine pathogens and represents a persistent threat to intensive production systems.

A separate genotyping proposal, based on reassembled viral gene sequences incorporating concatenated Rep, ORF3, and Cap coding sequences, has suggested a more complex classification scheme comprising three genogroups with multiple subtypes (e.g., genotype 1, genotype 2, genotype 3 with subtypes a through h) [16]. This alternative scheme, while not as widely adopted, highlights the ongoing refinement of PCV3 taxonomy. Coinfection with PCV2 is a frequent occurrence, with PCV3/PCV2 coinfection rates at the farm level historically reaching 47% in US herds, although this rate plummeted to 3% after the widespread introduction of PCV2 vaccines in 2006, suggesting a potential ecological interaction between these two circoviruses [3, 10, 12].

Molecular Pathogenesis of Porcine Circovirus 3: Replication, Immune Modulation, and Cellular Injury

The molecular pathogenesis of porcine circovirus 3 (PCV3) represents a complex, multifactorial process that distinguishes it from its better-characterized relative, PCV2, while sharing fundamental features common to the Circoviridae family. Since its initial identification in 2016, PCV3 has been implicated in a spectrum of clinical manifestations, including porcine dermatitis and nephropathy syndrome (PDNS), multisystemic inflammation, reproductive failure, and subclinical infections [2, 9]. Understanding the precise molecular mechanisms that underpin viral replication, immune evasion, and cellular injury is critical for developing effective control strategies and interpreting the growing body of epidemiological and pathological evidence. The virus’s broad tissue tropism, systemic dissemination, and capacity for both horizontal and vertical transmission [2, 20] set the stage for a pathogenic cascade that is only now being elucidated at the molecular level.

Genomic Architecture and Replication Strategy

PCV3 possesses a small, single-stranded, closed circular DNA genome of approximately 2000 nucleotides [1, 7]. The genome encodes two primary open reading frames (ORFs): ORF1, which encodes the replicase (Rep) protein essential for rolling-circle replication, and ORF2, which encodes the capsid (Cap) protein, the sole structural component of the virion and the primary antigenic target. A third, smaller ORF (ORF3) has been identified, and its protein product is increasingly recognized as a key mediator of cellular injury and apoptosis [17]. The replication strategy of PCV3 is intimately linked to the host cell's DNA replication machinery. As a small DNA virus, PCV3 lacks its own DNA polymerase and is therefore dependent on host enzymes active during the S-phase of the cell cycle. The Rep protein initiates replication by nicking the double-stranded replicative intermediate at a specific origin of replication, followed by rolling-circle amplification. This dependence on host replication machinery likely contributes to the virus's tropism for actively dividing cells, which may be found in lymphoid tissues and the developing fetus. The high genetic stability of PCV3 across decades and geographic regions, with nucleotide identities consistently exceeding 96-99% at both the complete genome and ORF2 levels [3, 8, 19], suggests an efficient and well-adapted replication cycle. This stability, however, does not preclude the emergence of distinct genotypes (PCV3a, PCV3b, and PCV3c) that exhibit subtle, yet potentially significant, differences in their capsid proteins [5, 9, 14, 15].

The Capsid Protein as a Determinant of Tropism and Immune Modulation

The Cap protein is the nexus of PCV3 pathogenesis, fulfilling roles in host cell attachment, entry, and the elicitation of the host immune response. Unlike the highly variable Cap of PCV2, the PCV3 Cap is remarkably conserved, yet specific amino acid substitutions have been linked to genotype emergence and potential shifts in pathogenicity. Phylogenetic analyses have consistently identified signature residues at positions 24, 27, 77, and 150 of the Cap protein that define the major genotypes [3, 14]. For instance, PCV3a strains are characterized by a distinct pattern of residues (VKSI) at these positions, a pattern not consistently found in PCV3b or PCV3c isolates [14]. More critically, mutations at positions 24 (A24V) and 27 (R27K) have been identified under diversifying selection pressure and lie within regions predicted to be antibody recognition domains [3, 12]. The A24V mutation has been shown to alter the structural folding of the Cap, changing a region from an alpha helix to a coiled structure, which could directly impact the presentation of epitopes to the immune system [3]. This structural remodeling suggests a mechanism for subtle immune evasion, allowing the virus to persist in the face of a humoral response.

Furthermore, the Cap protein is the primary target of the host adaptive immune response. Linear B-cell epitope mapping has identified multiple epitopic regions within the Cap, and critically, amino acid variation sites have been found to reside within these regions [5]. This implies that even minor genetic drift in the ORF2 gene could lead to antigenic variation, potentially enabling the virus to escape antibody neutralization. A notable example is the F104Y mutation, which lies within a predicted T-cell epitope and has been observed across PCV3c, PCV3b, and PCV3a3 subtypes [3]. Alterations in T-cell epitopes could impair cytotoxic T-lymphocyte (CTL) responses, which are crucial for clearing virus-infected cells. This dual pressure, to evade both humoral and cellular immunity, drives the selection of specific Cap variants. The binding of the Cap protein to host cell receptors likely involves interactions with heparan sulfate moieties, similar to PCV2, though the specific receptor for PCV3 remains to be definitively identified. The high-titer detection of PCV3 in testicular fluids and its efficient vertical transmission [20] underscore the virus's ability to establish infection in immunologically privileged sites and reproductive tissues, likely facilitated by Cap-mediated attachment.

ORF3 Protein and the Induction of Apoptosis

A cornerstone of PCV3-induced cellular injury is the activity of the ORF3 protein. In the broader Circoviridae family, the ORF3 protein is a well-established inducer of apoptosis, a form of programmed cell death [17]. For PCV2, the ORF3 protein has been shown to interact with host cellular proteins, including the p53 tumor suppressor and the PHLPP1 phosphatase, to trigger the intrinsic (mitochondrial) apoptotic pathway. This mechanism is highly conserved within the family, including in chicken anemia virus, where the ORF3 homolog, apoptin, is famed for its ability to selectively induce apoptosis in cancer cells [17]. The PCV3 ORF3 protein is predicted to function through analogous pathways. The induction of apoptosis by ORF3 serves a dual viral purpose: it facilitates the release of progeny virions from infected cells and dismantles the host's immune architecture by depleting critical immune cell populations.

This pro-apoptotic activity is the molecular underpinning of the hallmark histopathological lesion of PCV3-associated disease (PCV3-AD): systemic nonsuppurative periarteritis and arteritis [2]. The destruction of lymphocytes and other mononuclear cells within the vascular adventitia and media, likely driven by ORF3-induced apoptosis, leads to the characteristic inflammatory lesions seen in multiple organs, including the heart, kidneys, and mesenteric arterial plexus [2]. The loss of T and B lymphocytes in lymphoid tissues, a phenomenon observed in PCV2 infections, is also a suspected consequence of PCV3 replication, resulting in a state of immunosuppression that predisposes the host to secondary infections. The activation of caspases, the central executioners of apoptosis, is a direct consequence of ORF3 expression. While the specific host partners of PCV3 ORF3 are still being identified, the conservation of this pathogenic mechanism across circoviruses is undeniable. The ability to trigger apoptosis in diverse cell types, including endothelial cells and immune cells, explains the multisystemic nature of PCV3-AD.

Immune Modulation and Subversion of Host Defenses

Beyond the direct cytopathic effects of apoptosis, PCV3 employs sophisticated strategies to modulate the host immune response. The presence of PCV3 nucleic acids in apparently healthy pigs and cattle [2, 18], along with its high prevalence in subclinical infections [2, 3], indicates a remarkable capacity for immune evasion and persistence. One key mechanism is the modulation of cytokine responses. While not as extensively studied as PCV2, it is plausible that PCV3, like its counterpart, can skew the immune system toward a regulatory or anti-inflammatory profile. PCV2 is known to induce interleukin-10 (IL-10), an immunosuppressive cytokine that dampens the activity of dendritic cells and T cells, thereby limiting the development of a robust antiviral response. The detection of PCV3 in clinically healthy reservoir species, such as cattle, with no overt pathology [18] suggests that the virus can establish a balanced, persistent infection, where viral replication is tolerated by the host's immune system without causing significant disease. The negative correlation observed between PCV3 DNA load and anti-capsid antibody titers in some studies [14] further supports the idea that the humoral response may be suboptimal or dysregulated.

The structural modifications in the Cap protein, discussed previously, are a primary form of immune evasion. By altering the conformation of key epitopes, the virus can reduce the efficacy of neutralizing antibodies. This is particularly relevant in the face of prior exposure or maternal immunity, where a suboptimal antibody response may fail to clear the infection but can paradoxically enhance entry into certain cell types through antibody-dependent enhancement (ADE). The presence of multiple, genetically distinct PCV3 genotypes circulating within the same region [9, 14, 15] challenges the host's immune system to mount a broadly protective response. The high level of sequence identity among PCV3 strains suggests that even minor changes can have outsized effects on immune recognition. This antigenic drift, combined with the induction of apoptosis in immune cells, creates a permissive environment for viral replication and persistence. The virus's ability to be shed in oral fluids and feces [14] further facilitates its spread among susceptible hosts, perpetuating the cycle of infection.

Cellular Injury and Pathological Consequences

The culmination of these molecular processes, viral replication, ORF3-induced apoptosis, and immune modulation, is a distinct pattern of cellular injury that defines PCV3-AD. The central lesion is systemic vasculitis, targeting the small and medium-sized arteries and veins. Microscopically, this presents as a necrotizing inflammation of the vessel wall, with infiltration of mononuclear cells (lymphocytes and macrophages) and edema. The resultant damage leads to vascular thrombosis, ischemia, and infarction, causing the clinical signs of PDNS (e.g., reddened skin lesions) and multisystemic inflammation. The presence of viral nucleic acids within these vascular lesions [2] confirms that direct viral infection of endothelial cells and perivascular macrophages is a primary driver of the pathology. In the heart, this manifests as myocarditis and pericarditis; in the kidneys, it leads to interstitial nephritis; and in the reproductive tract, it causes placentitis and subsequent abortion or stillbirth [2].

In the fetus, the pathogenesis centers on the replication of PCV3 in the highly mitotically active tissues of the developing conceptus. The induction of apoptosis in trophoblasts and fetal endothelial cells by ORF3 compromises placental integrity and blood supply, leading to fetal demise and mummification. The high rate of PCV3 detection in testicular fluids [20] highlights the male reproductive tract as a significant site of viral replication and a potential vector for vertical transmission. In piglets and grower pigs, the virus targets lymphoid tissues, leading to lymphoid depletion and atrophy. This immunosuppression is a critical pathogenic event, as it opens the door for co-infections with other viral (e.g., PCV2, PRRSV) or bacterial pathogens, which are commonly observed in PCV3-AD cases [2, 4, 12]. The synergistic interaction between PCV3 and other agents amplifies the severity of clinical disease, making PCV3 a significant contributor to the porcine respiratory disease complex (PRDC) and other polymicrobial syndromes.

The link between PCV3 infection and enteric disease is also becoming clearer. Detection of PCV3 in diarrheic piglets and its association with villous atrophy in the small intestine [13] suggests that the virus can directly damage the intestinal epithelium, potentially through ORF3-induced apoptosis of enterocytes, leading to malabsorption and diarrhea. The identification of the virus in the central nervous system of pigs with encephalomyelitis (though primarily associated with other pathogens) hints at a broad tissue tropism that extends to neural tissues. The molecular basis for this tropism may lie in the recognition of ubiquitously expressed cell surface receptors or in the ability of the ORF3 protein to interact with host proteins that regulate cell survival in a wide array of cell types. The cumulative effect of these pathological processes is a significant economic burden on the swine industry due to reproductive losses, increased mortality, and reduced growth performance.

The interplay between PCV3 replication, its capacity to induce apoptosis through the ORF3 protein, and its ability to modulate the host immune response via capsid-driven epitopic variation creates a pathogenic triad that is responsible for the diverse clinical manifestations of PCV3-AD. Ongoing research continues to refine the molecular details of these interactions, which are essential for developing next-generation vaccines and diagnostic tools.

Epidemiology of Porcine Circovirus 3: Global Distribution, Genotypes, and Cross-Species Infections

The epidemiological landscape of Porcine Circovirus 3 (PCV3) has undergone a dramatic transformation since its initial identification in 2016, evolving from a novel pathogen of uncertain significance to a globally recognized endemic agent of swine. Understanding its distribution, the complex interplay of its genotypes, and its expanding host range is fundamental to assessing its true economic and health impact on the global swine industry. This section provides an exhaustive analysis of these critical epidemiological dimensions.

Global Distribution and Spatiotemporal Prevalence

PCV3 is now recognized as a ubiquitous virus in swine populations worldwide, with a presence that significantly predates its formal discovery [2, 3]. Retrospective analyses have been pivotal in establishing this ancient footprint. In the United States, PCV3 was detected in serum samples from grower-finisher herds dating back to 2000, demonstrating a farm-level prevalence of 47% at that time, which subsequently decreased to 22% by 2012 [3]. Similarly, diagnostic data from six US veterinary diagnostic laboratories (VDLs) spanning from 2002 to 2023 revealed an upward trend in PCV3 positivity after its first report in 2016, with detections peaking in spring 2023 [10]. This pattern suggests the virus was circulating endemically, likely underdiagnosed, before gaining clinical attention.

The most compelling evidence for PCV3's historical circulation comes from China. A landmark study analyzing porcine clinical samples collected between 1990 and 1999 from 20 provinces identified PCV3-positive samples as early as 1996, with an overall prevalence of 6.5% [8]. This finding firmly establishes a nearly two-decade history of the virus in Asian swine herds. Subsequent large-scale surveys have confirmed its entrenched endemicity. Between 2018 and 2022, a study of 2,707 serum samples from 17 Chinese provinces revealed an overall sample-level positivity of 31.07% (841/2707) and a province-level detection rate of 100% (17/17), with positivity rates ranging dramatically from 7.41% to 70.0% across different provinces [9]. More recent surveillance in Hunan Province (2021–2024) found a 29.4% (206/700) positivity rate in lymph node tissues collected from slaughterhouses and disposal centers, with the highest prevalence (56%) observed in Yiyang City, while no positive samples were detected in Zhuzhou City, highlighting significant regional variation [5].

Beyond Asia and North America, PCV3 has been documented across Europe, the Americas, Africa, and the Caribbean. In Europe, an investigation in Northern Italy revealed a critical ecological gradient: the infection risk was significantly higher in wild boars and rural (backyard) pigs compared to those in intensive commercial farms [6]. This study demonstrated a larger viral population size in wild and rural populations and estimated a preferential viral flow from these reservoirs into commercial herds, underscoring the threat posed by non-commercial pig populations [6]. In the Caribbean, the first report of PCV3 in pigs from the Dominican Republic found a 21% (21/100) detection rate in diarrheic pigs, with the highest rates (35.3% each) observed in piglets and growers [4]. In Africa, initial molecular characterization from pigs in Tanzania (2018–2022) has confirmed the presence of PCV3, though with limited genetic heterogeneity observed [19]. The pattern is clear: PCV3 is not merely present but is actively circulating in diverse production systems and geographical regions, often at substantial prevalence rates.

Genotypic Diversity and Evolutionary Dynamics

The genotypic classification of PCV3 has evolved as sequence data from around the world have accumulated. Three major genotypes are currently recognized, PCV3a, PCV3b, and PCV3c, though further sub-clades continue to be described [3, 5, 14, 16]. A comprehensive genotyping scheme based on reassembled viral gene sequences (replicase, ORF3, and capsid) suggested a classification into three main genotypes with multiple subtypes, including subtypes a-h for genotype 3 [16]. The global distribution of these genotypes is dynamic and subject to shifting prevalence patterns.

PCV3a is the most widely distributed genotype, found across North America, Asia, Europe, and the Caribbean. In the United States, a retrospective study of 28 PCV3 ORF2 sequences from 2000, 2006, and 2012 identified a variety of subtypes: PCV3a1 (1/28), PCV3a2 (4/28), PCV3a3 (19/28), PCV3b (2/28), and PCV3c (2/28) [3]. The predominance of PCV3a3 in the US historical dataset is notable. In the Dominican Republic, all 11 complete genome sequences analyzed clustered within PCV3a (Clade-1), sharing >98% sequence identity with other global PCV3a strains [4]. In China, while PCV3a and PCV3b were initially reported as the predominant subtypes in a nationwide study from 2018–2022 [9], more recent data from Hunan Province (2021–2024) revealed a striking shift: PCV3c was the dominant genotype (67.6%, 23/34), followed by PCV3a (32.4%, 11/34), with PCV3b not detected at all [5]. A study of Tibetan pigs on the Qinghai-Tibet Plateau found a co-circulation of all three genotypes, with PCV3a (40%), PCV3b (25%), and PCV3c (35%) [15]. Interestingly, PCV3a was more frequently associated with diarrheic pigs in that study, while PCV3c was more common in healthy animals [15]. These data indicate that while PCV3 is genetically stable (nucleotide identities of 96.6-100% between strains over decades [8, 12]), specific genotypes can shift in dominance geographically and temporally.

The evolutionary pressures driving PCV3 diversity are primarily concentrated in the capsid (Cap) protein, the target of host immune responses. A detailed analysis of US sequences from 2000 to 2012 identified diversifying selection at amino acid positions 24 and 150 in 2006, and at positions 24 and 27 in 2012 [3]. The mutations A24V and R27K are common across all PCV3 subtypes [3, 12]. Structural modeling revealed that the substitution at amino acids 24 and 27 changed the secondary structure from an alpha helix to a coiled conformation in 2012 sequences, potentially altering antibody recognition [3]. Other significant mutations include S77T and I150L, which are common within the PCV3a2 subtype [3]. The F104Y mutation lies within a predicted T-cell epitope and is present in PCV3c, PCV3b, and PCV3a3 subtypes [3]. In sequences from Southwest China, three mutations (A24V, R27K, and E128D) were identified in antibody recognition domains of the Cap protein, potentially linked to immune escape [12]. An analysis of 34 Cap gene sequences from Hunan identified twelve amino acid substitution sites, with ten of these located within predicted B-cell linear epitopes [5]. The ORF2 nucleotide identity across global strains remains high (97.46-100%), but these specific residues under selection highlight the virus's ongoing adaptation [3, 5, 9, 12].

Cross-Species Infections and Reservoir Hosts

A defining epidemiological feature of PCV3 is its ability to infect and circulate in a range of non-porcine hosts, raising critical questions about reservoir dynamics and potential spillback events. The virus's detection in cattle is particularly well-documented. In Shandong province, China, an investigation of 213 bovine samples found 74 (34.7%) positive for PCV3 DNA [1]. Phylogenetic analysis of bovine-origin strains grouped them into PCV3a, closely related to the US strain PCV3-US/SD2016, and a notable amino acid mutation (D124 to Y124) was identified in the Cap protein [1]. A larger retrospective study of 1,499 clinically healthy cattle in the same province from 2011 to 2018 found a 28.95% (434/1,499) positivity rate [18]. Importantly, sequencing of 27 cap genes from these bovine samples grouped them all within PCV3b, suggesting that a different genotype circulates in cattle compared to the PCV3a initially reported [18]. Critically, infected cattle showed no clinical symptoms, yet they may serve as a significant reservoir and potentially transfer the virus back to pigs [18]. This asymptomatic carriage in a food-producing species has implications for biosecurity and herd management.

Wild boar populations represent a major sylvatic reservoir for PCV3. In Northern Italy, PCV3 occurrence was significantly higher in wild boars compared to commercial pigs, and phylodynamic analysis confirmed a larger viral population size and preferential viral flow from wild boar and rural pigs to commercial pigs [6]. A significant viral flow from wild boar to rural animals was also proven [6]. In Jiangxi Province, China, a study of 138 wild boar samples detected PCV3 in 5.8% (8/138) of animals, with co-infections of PCV2 and PCV3 occurring in 3.6% of samples [23]. These findings highlight that wild boar act not merely as sentinels but as active maintenance hosts and potential sources of viral introduction into domestic herds, complicating eradication or control efforts.

The detection of PCV3 in laboratory mice (Mus musculus) is a particularly concerning discovery. Commercially sourced Balb/C and ICR mice from China were found to be universally positive for PCV3 DNA (20/20 serum samples) [7]. The complete genomes amplified from these mice shared 97.9–98.8% nucleotide identity with porcine PCV3 strains, and phylogenetic analysis of ORF2 sequences showed they clustered within the same clade as porcine isolates [7]. This finding presents a dual concern: first, it provides a potential small animal model for studying PCV3 pathogenesis, and second, it poses a potential hazard to the swine industry if contaminated laboratory materials or fomites are transferred to pig facilities [7]. The presence of PCV3 in laboratory rodents also raises questions about the virus's true host range, potentially including wild rodents that could act as bridging vectors.

Beyond cattle, swine, and mice, PCV3 has been detected in a variety of other species, demonstrating a remarkably broad tissue tropism and host range. The virus has been identified in dairy cows, raccoon dogs, and foxes, highlighting its ability to circulate in both domestic and wild carnivores [21, 22]. Although these reports are primarily from China, they suggest a much wider ecological niche than initially anticipated. The detection of PCV3 in foxes and raccoon dogs is particularly interesting, as these are peri-domestic animals that frequently scavenge near farms, potentially acting as mechanical or biological vectors. The cumulative evidence indicates that PCV3 is not a swine-specific pathogen but rather a multi-host circovirus with a reservoir network that spans domestic livestock, wildlife, and even laboratory animals. This cross-species capacity has profound implications for the long-term control of PCV3-associated diseases, as eradication from swine populations alone may be insufficient if the virus continues to circulate in cattle, wild boar, and other reservoir hosts.

Diagnostic Challenges and Advances for Porcine Circovirus 3: Molecular, Serological, and Pathological Approaches

Since its initial identification in 2016, porcine circovirus 3 (PCV3) has presented formidable diagnostic challenges that continue to confound veterinary diagnosticians, pathologists, and epidemiologists. The virus is now recognized as a ubiquitous pathogen within global swine populations, frequently associated with subclinical infections across all production stages, yet capable of inducing a spectrum of disease manifestations collectively termed PCV3-associated diseases (PCV3-AD). These include reproductive disorders such as mummified fetuses, stillbirths, and weak neonates, as well as postnatal presentations encompassing anorexia, weight loss, progressive wasting, and systemic nonsuppurative periarteritis and arteritis observed across multiple tissues, particularly the heart, mesenteric arterial plexus, and kidneys [2]. The true prevalence of PCV3-AD under field conditions is likely underestimated, a reality directly attributable to the limited availability, high costs, and interpretive complexities of definitive laboratory techniques [2]. The diagnostic landscape for PCV3 is further complicated by the virus’s broad tissue tropism, high genetic stability yet emerging diversity, frequent co-infections with other pathogens, notably PCV2, and the critical necessity of correlating viral detection with compatible histopathological lesions to establish causation.

Molecular Detection: The Cornerstone and Its Complexities

The detection of PCV3 nucleic acid has become the primary diagnostic modality, with conventional PCR, quantitative real-time PCR (qPCR), and increasingly sophisticated platforms forming the backbone of molecular surveillance. The development of a TaqMan-based qPCR targeting the conserved replicase (REP) gene achieved a remarkable sensitivity of 7.3 × 10⁰ copies/µL, with inter- and intra-assay coefficients of variation below 1%, demonstrating exceptional reproducibility and specificity with no cross-reactivity against other common porcine pathogens [20]. This assay’s utility was further validated through the analysis of 2,454 clinical samples, revealing the highest prevalence in testicular fluid (71.28%) with the lowest Cq values, underscoring significant vertical transmission potential, while oral fluids exhibited a 59.83% positivity rate, highlighting their importance for monitoring fattening herds from a veterinary management perspective [20].

Multiplex platforms have addressed the pressing need for differential diagnosis in the context of co-circulating circoviruses. A TaqMan-probe-based multiplex qPCR for simultaneous detection and differentiation of PCV2, PCV3, and PCV4 demonstrated detection limits of 10¹ copies/µL, with no cross-reactivity and intra- and inter-group coefficients of variation below 2% [24]. Application to 535 clinical samples from East China between 2020 and 2022 revealed individual positive rates of 35.33%, 40.37%, and 33.08% for PCV2, PCV3, and PCV4, respectively, with mixed infection rates of PCV2 and PCV3 at 31.03% and triple co-infection at 28.22% [24]. Such high co-infection rates confound the attribution of clinical signs to a single etiological agent and emphasize the need for multiplex approaches.

A significant advancement in interpreting molecular data was the establishment of an interpretative PCR cycle threshold (Ct) cutoff for PCV3 diagnosis. Analysis of 20 years of diagnostic data from six United States veterinary diagnostic laboratories (2002–2023) revealed that a Ct value of 26.7 was associated with the highest performance for confirming PCV3 clinical disease through histopathology, providing a critical interpretative threshold for clinicians and diagnosticians [10]. This finding is particularly important given that PCV3 DNA is frequently detected at low levels in clinically healthy animals, and the absence of a standardized cutoff has historically led to over-interpretation of subclinical infections.

The emergence of isothermal amplification technologies represents a paradigm shift for on-site, resource-limited diagnostics. A recombinase-aided amplification (RAA) assay combined with Pyrococcus furiosus Argonaute (PfAgo) targeting a conserved 41-bp region within the ORF2 gene achieved a limit of detection of 1 copy/µL, completing amplification and detection within 35 minutes with high specificity and no cross-reactivity [25]. A semi-quantitative cutoff-based classification strategy inspired by ELISA analysis was introduced to robustly discriminate positive from negative samples under variable background conditions, and evaluation of 107 clinical samples showed complete concordance with reference TaqMan qPCR [25]. Furthermore, a duplex real-time RAA assay for simultaneous detection of PCV3 and PCV4 achieved completion within 20 minutes at 39°C, with a detection limit of 73.67 copies/reaction and kappa values of 0.966 and 1 for PCV3 and PCV4 respectively compared to qPCR [29]. These advances enable rapid, instrument-flexible detection that is critical for early outbreak recognition and biosecurity interventions.

Next-generation sequencing (NGS) and metagenomics have revolutionized our understanding of PCV3 epidemiology, evolution, and the broader virome. NGS-based protocols optimized for veterinary diagnostic laboratories have successfully identified PCV3 in complex matrices and facilitated complete genome characterization [27]. Metagenomic studies have been instrumental in uncovering PCV3’s presence in seemingly unrelated clinical presentations, such as its detection alongside Getah virus, porcine kobuvirus, and porcine bocavirus in abortion cases, highlighting the complex viral coexistence patterns that complicate etiological attribution [28]. The ability of NGS to detect both known and novel viruses, coupled with the development of standardized sample preparation protocols, optimized for porcine samples spiked with various DNA and RNA viruses, has positioned this technology as a powerful surveillance tool [27, 33].

Serological Approaches: Bridging the Gap Between Exposure and Disease

Serological diagnostics for PCV3 have lagged behind molecular methods, principally due to the challenges in producing high-quality recombinant antigens and the delayed or inconsistent antibody responses observed in infected animals. The capsid (Cap) protein, the primary immunogenic target, has been expressed using prokaryotic systems to develop serological assays. A double-antibody sandwich ELISA (DAS-ELISA) developed using a monoclonal antibody (mAb 4G1) targeting a highly conserved linear epitope (³⁷DYYDKK⁴²) within the first β-sheet of the Cap structure, exhibiting 99.35% conservation across 1,247 sequences, achieved a detection limit for positive pig serum of 1:800, a linear detection range for Cap protein down to 3.4 ng/mL, and a 93.33% coincidence rate with qPCR (kappa = 0.837) [11]. This assay showed no cross-reactivity with other swine pathogens and presented a simple, sensitive, and operationally efficient alternative for serosurveillance [11].

Retrospective serological investigations have provided profound insights into the historical circulation of PCV3. Indirect ELISA using recombinant Cap protein coating revealed an average seropositive rate of 52.6% (range 40.8–60.8%) across 2,345 serum samples collected in Zhejiang Province, China, from 2011 to 2017 [14]. Critically, high positive findings were identified in samples as early as 2012, suggesting PCV3 emergence in China predated its first genetic description in 2016 by several years [14]. The same study noted a negative correlation between PCV3 DNA levels and anti-capsid antibody response, indicating that viremia may suppress or delay humoral immunity, thereby complicating the interpretation of serological results in acutely infected animals [14].

The interplay between serology and molecular detection remains problematic. In a comparative analysis of 203 serum samples, qPCR detected more positives than ELISA (81.3% vs. 56.2%), and among 89 samples seronegative by ELISA, 81 were found positive by qPCR [14]. This discordance likely reflects the window period between infection and seroconversion, the immunosuppressive effects of PCV3 itself, or the presence of maternally derived antibodies in young animals that may interfere with serological interpretation. Consequently, reliance on serology alone for acute diagnosis is inadvisable, and serological data are best employed for population-level exposure assessments and retrospective epidemiological investigations.

Pathological Challenges: Defining the Gold Standard

The histopathological hallmark of PCV3-AD is systemic nonsuppurative periarteritis and arteritis, observed across multiple tissues including the heart, mesenteric arterial plexus, and kidneys [2]. The diagnosis of PCV3-AD requires the confluence of three criteria: characteristic clinical signs (reproductive failure, wasting, PDNS-like lesions), compatible histopathological findings (lymphohistiocytic to granulomatous inflammation, particularly perivascular and intravascular), and in situ detection of the virus within lesions [2]. The latter criterion is paramount because PCV3 nucleic acid can be detected in diverse tissues from clinically healthy animals, and the presence of viral DNA alone does not confirm disease causation.

The challenge of attributing pathology to PCV3 is compounded by the high prevalence of co-infections. In studies examining PCV3-positive tissues, the presence of PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and a myriad of other pathogens frequently confounds lesion attribution [26, 28]. The Porcine Translational Research Database, a manually curated genomics and proteomics resource, underscores the complexity of porcine immunology and the need for robust annotation of immune response genes to understand host-pathogen interactions during PCV3 infection [31]. This resource has identified and corrected over 8,000 errors in porcine gene databases, providing critical tools for studying the molecular pathogenesis of PCV3 [31].

Immunohistochemistry (IHC) and in situ hybridization (ISH) are essential for linking viral presence to pathology. However, the availability of validated antibodies for PCV3-specific IHC is limited. The development of the mAb 4G1 targeting the conserved Cap epitope represents a promising step forward, but its application to formalin-fixed, paraffin-embedded tissues has not been extensively validated [11]. The use of ISH, as demonstrated for porcine bocavirus encephalomyelitis [30], offers a potential path forward for spatial localization of PCV3 nucleic acid within lesions. The capacity to detect intraneuronal or intravascular viral signals adjacent to inflammatory infiltrates would provide definitive evidence of a causal relationship.

The clinical-pathological correlation is further obscured by the variability in PCV3 tissue tropism and the lack of a standardized lesion scoring system. While the heart, kidneys, and mesenteric arteries are consistently implicated, the severity of lesions is highly variable and may be influenced by host age, immune status, and co-infection pressures. The establishment of an interpretative Ct cutoff of 26.7 for histopathological confirmation marks a significant step toward standardization, but the biological basis for this threshold, reflecting the viral load required to trigger a threshold inflammatory response, remains incompletely understood [10].

Emerging Diagnostic Frontiers and Remaining Challenges

The integration of photonic integrated circuits and microfluidics into point-of-care diagnostic devices represents a transformative frontier for PCV3 detection. A novel system utilizing photonic biosensors and microfluidics achieved detection of PCV2 in oral fluids within 75 minutes, with a limit of detection of 3.3 × 10⁵ copies/mL and area under the ROC curve of 0.742 [32]. Although this platform was developed for PCV2, the underlying technology, based on refractive index changes upon viral binding, is adaptable to PCV3 and could provide real-time, on-farm diagnostic capacity [32].

The genetic stability of PCV3, long considered a hallmark, is increasingly challenged by evidence of ongoing evolution. Genotyping efforts have classified PCV3 into three major genotypes (PCV3a, PCV3b, PCV3c) with multiple subtypes, using a model combining replicase, ORF3, and capsid protein coding genes for optimal clade support [16]. Sequence analysis has identified diversifying selection at amino acids 24 and 27 of the Cap protein, with substitutions A24V and R27K common across all subtypes, and molecular modeling revealing a change from alpha helix to coiled structural folding in sequences from 2012 compared to earlier isolates [3]. Mutation F104Y lies within a predicted T-cell epitope, potentially impacting immune recognition [3]. The identification of a unique deletion at nucleotide residue 1165 in a Dominican Republic strain further underscores the need for continuous molecular surveillance to ensure diagnostic primers and probes remain relevant [4].

Perhaps the most daunting challenge for PCV3 diagnostics is the virus’s capacity to infect a broad range of hosts, including cattle, wild boar, mice, and potentially other species. Detection of PCV3 in 34.7% of bovine samples in Shandong Province, China, with complete genome identities of 97.5–99.8% to porcine reference strains, raises questions about cross-species transmission and the role of non-porcine reservoirs in viral maintenance [1]. Retrospective analysis of 1,499 healthy cattle from 2011 to 2018 found 28.95% positive for PCV3 DNA, with all sequenced cap genes belonging to PCV3b, indicating sustained circulation in a non-porcine reservoir [18]. Furthermore, detection of PCV3 in 100% of commercially sourced laboratory mice (Balb/C and ICR strains) with 97.9–98.8% genome homology to porcine strains suggests that laboratory rodents could serve as inadvertent reservoirs and complicate experimental studies [7]. The higher infection risk and viral flow from wild boar and rural pig populations to commercial farms, as demonstrated in northern Italy, underscores the interconnectedness of these populations and the diagnostic blind spots inherent in focusing surveillance solely on commercial swine [6].

In conclusion, the diagnostic landscape for PCV3 is characterized by remarkable advances in molecular sensitivity and speed, the development of serological tools with high concordance to PCR, and a refined understanding of pathological correlates. Yet the challenges of interpreting widespread subclinical detection, attributing disease causation in the face of ubiquitous co-infections, standardizing histopathological interpretation, and accounting for cross-species transmission persist. The field must now focus on validating interpretative thresholds across diverse populations, developing standardized lesion scoring systems, expanding the repertoire of in situ detection tools, and integrating point-of-care technologies to support field-level decision-making. Only through such comprehensive diagnostic approaches can the true impact of PCV3 on global swine health and production be accurately assessed.

Clinical Manifestations and Lesions Associated with Porcine Circovirus 3 in Swine

The clinical and pathological landscape of Porcine Circovirus 3 (PCV3) infection in swine is complex, ranging from clinically inapparent, subclinical infections to severe, multisystemic disease states that can result in significant economic losses. The virus, first identified in 2016, has been retrospectively detected in swine populations as early as 1996, indicating a long-standing, albeit initially unrecognized, presence [8]. The constellation of clinical signs and lesions now collectively termed PCV3-associated disease (PCV3-AD) encompasses reproductive failure, postnatal systemic inflammation, and enteric disease, with a histopathological hallmark of systemic nonsuppurative periarteritis and arteritis [2]. It is critical to recognize that PCV3 is frequently detected in healthy animals, complicating the attribution of causality and underscoring the necessity of integrating clinical, pathological, and virological evidence for a definitive diagnosis [2, 10].

Reproductive Manifestations

One of the most economically impactful manifestations of PCV3-AD is reproductive failure in breeding herds. Clinically, affected sows may present with abortions, increased numbers of mummified fetuses, stillbirths, and the delivery of weak, non-viable neonates [2, 8]. The virus exhibits a marked tropism for the reproductive tract, with a high prevalence of viral DNA detected in testicular fluid samples (71.28%), suggesting a significant potential for vertical transmission from boars to sows and subsequently to offspring [20]. This finding aligns with the observation that PCV3 detection is more frequent in adult sows and breeding herds compared to younger age groups, reinforcing the reproductive sphere as a primary site of clinical impact [10]. The pathogenesis likely involves infection of the fetal tissues, leading to vascular damage in the placenta and fetus, which precipitates hypoxia, developmental arrest, and eventual death. The lesions in aborted or stillborn fetuses are consistent with systemic inflammation and vascular injury, mirroring the hallmark lesions seen in postnatal disease.

Postnatal Clinical Syndromes

In nursery, grower, and finisher pigs, the clinical presentation of PCV3-AD is more heterogeneous but can be broadly categorized into systemic, respiratory, enteric, and cutaneous forms.

Progressive Wasting and Systemic Inflammation: A classic presentation involves progressive weight loss, unthriftiness, anorexia, and lethargy, often described as a wasting syndrome [2, 8]. These animals fail to thrive and exhibit poor body condition. This systemic manifestation is the postnatal counterpart to the reproductive disease and is driven by the disseminated vascular pathology. The inflammatory process, primarily a nonsuppurative inflammation of the arterial walls, can affect virtually any organ system, leading to multisystemic inflammation [2]. This systemic inflammatory state is a key differentiator from other porcine circovirus-associated diseases, such as those caused by PCV2.

Porcine Dermatitis and Nephropathy Syndrome (PDNS)-Like Lesions: PCV3 has been strongly associated with clinical signs and lesions that are indistinguishable from porcine dermatitis and nephropathy syndrome (PDNS), a condition originally linked predominantly to PCV2 [8, 9, 12, 13]. Affected pigs develop characteristic, well-demarcated, red-to-purple macules and papules on the skin, most notably on the hindquarters, perineum, flanks, and ears. Concurrently, renal involvement manifests as nephropathy, with animals showing signs of renal failure, though this is often detected only at necropsy [8]. The skin lesions result from a necrotizing vasculitis, a direct consequence of the systemic arteritis that defines PCV3 infection.

Respiratory and Enteric Signs: Respiratory disease, characterized by coughing, dyspnea, and tachypnea, is also frequently reported in PCV3-positive pigs [8, 35]. While PCV3 can be a primary agent, it is important to note that it is frequently found in co-infections with other respiratory pathogens, such as PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and Mycoplasma hyorhinis, which can exacerbate the clinical severity [26, 34]. Similarly, enteric disease, particularly diarrhea in suckling and weaned piglets, is a significant clinical presentation [4, 13, 15]. Studies have shown a higher prevalence of PCV3 in diarrheic piglets compared to healthy ones, with detection rates in diarrheal samples reaching up to 27.28% in suckling pigs [13, 15]. The diarrhea is likely multifactorial, stemming from both the direct cytopathic effects of the virus on the intestinal epithelium and the systemic vascular inflammation that disrupts gut function.

Pathognomonic Histopathological Lesions: Systemic Periarteritis and Arteritis

The definitive diagnosis of PCV3-AD is contingent upon the identification of its characteristic microscopic lesions, in conjunction with the detection of PCV3 nucleic acids within those lesions [2]. The pathognomonic lesion is a nonsuppurative, lymphohistiocytic periarteritis and arteritis, which can be observed across a wide range of tissues. The most commonly affected sites include the heart, kidneys, mesenteric arteries, and the pulmonary vasculature [2]. In the heart, this vasculitis can manifest as a lymphohistiocytic myocarditis and epicarditis, which can be severe and contribute to cardiac dysfunction. In the kidneys, the inflammation is centered on the small and medium-sized arteries, leading to interstitial nephritis and the clinical nephropathy observed in PDNS-like cases. The mesenteric arterial plexus is also a frequent target, and inflammation here can compromise intestinal blood flow, contributing to villous atrophy and enteric disease [2, 13].

Beyond the vascular lesions, other histological changes are common. In cases of enteric disease, moderate to severe villous atrophy in the duodenum, jejunum, and ileum has been documented, with a significantly decreased average height of villi and depth of crypts in PCV3-infected piglets compared to controls [13]. In the lung, interstitial pneumonia is a frequent finding, characterized by thickening of the alveolar septa due to inflammatory cell infiltration [2]. The consistent presence of viral antigens or nucleic acids, detected via immunohistochemistry or in situ hybridization, within these inflammatory lesions is the gold standard for confirming the etiological role of PCV3 [2, 30].

The Role of Viral Load, Co-infections, and Subclinical Infection

The clinical expression of PCV3 infection is highly dependent on viral load and the presence of concurrent infections. A quantitative PCR (qPCR) cycle threshold (Ct) cutoff of 26.7 has been proposed in diagnostic settings to correlate with a high probability of confirming PCV3-AD through histopathology [10]. This indicates that a high level of viral replication is required to induce disease. Subclinical infections are exceptionally common, with PCV3 being detected in a high percentage of clinically healthy pigs at slaughter, complicating the interpretation of diagnostic results [10, 18].

Co-infections are the rule, not the exception. PCV3 is frequently found alongside PCV2, and the rate of PCV2/PCV3 coinfection can be substantial, with studies reporting rates of 31.03% in East China [24]. Other common co-infecting agents include porcine epidemic diarrhea virus (PEDV), PRRSV, and various bacteria [14, 28, 36]. The presence of these co-pathogens can potentiate PCV3 replication and exacerbate the severity of clinical disease. Conversely, in cases of high mortality events due to primary bacterial septicemia (e.g., Streptococcus equi subsp. zooepidemicus), PCV3 may be detected inconsistently and at low levels, suggesting it is an incidental finding rather than the cause of the acute mortality [36]. This distinction underscores a critical principle: detection of PCV3 alone is insufficient for diagnosis; it requires careful clinicopathological correlation.

Diagnostic Challenges and Interpretations

A major challenge in assessing the true prevalence and impact of PCV3-AD is the high cost and limited availability of the specialized diagnostic techniques required for definitive diagnosis. While PCR is widely used to detect viral DNA, it cannot distinguish between a clinically significant infection and an incidental, subclinical presence [2]. The definitive diagnosis requires the histopathological identification of the characteristic arteritis and the confirmation of PCV3 within these lesions using in situ hybridization or immunohistochemistry [2]. Without this confirmation, many cases of PCV3-AD are likely misattributed to other pathogens or remain undiagnosed, leading to a significant underestimation of the disease's burden in the global swine industry [2]. The World Organisation for Animal Health (WOAH) recognizes the economic importance of porcine circoviruses, and the diagnostic challenges associated with PCV3 highlight the need for standardized, accessible diagnostic criteria to effectively monitor and control this emerging pathogen.

Transmission Dynamics and Reservoir Hosts of Porcine Circovirus 3: Implications for Biosecurity

Since its initial identification in 2016, porcine circovirus 3 (PCV3) has emerged as a ubiquitous pathogen with a global distribution, challenging the classical understanding of circovirus host specificity and transmission ecology. The epidemiological profile of PCV3 is defined by its ability to sustain itself across multiple host species, its capacity for both horizontal and vertical dissemination within swine populations, and its persistence across wide temporal and geographic scales. Understanding the nuanced dynamics of PCV3 transmission and the role of non-porcine reservoir hosts is not merely an academic exercise; it is a cornerstone for developing effective, evidence-based biosecurity protocols that are essential for controlling this economically relevant pathogen.

Mechanisms and Routes of Horizontal Transmission

The horizontal transmission of PCV3 is facilitated by multiple routes, reflecting its systemic tropism and shedding patterns. The virus is detectable in a wide array of biological matrices, including serum, oral fluids, feces, and various tissues, which collectively indicate that transmission can occur via direct contact, indirect contact through contaminated fomites, and potentially through the fecal-oral or respiratory routes. Studies utilizing quantitative PCR have demonstrated that PCV3 nucleic acid is most frequently detected in testicular fluid, with a positivity rate of 71.28% and the lowest Cq values among all sample types, suggesting a particularly high viral load in this matrix [20]. This finding has profound implications for biosecurity in breeding operations, as it highlights a potent and previously underappreciated mechanism for horizontal and potentially vertical transmission through contaminated semen or during natural mating. Furthermore, oral fluids exhibit a high positivity rate of 59.83%, making the collection of oral fluids a valuable tool for monitoring infection in group-housed pigs and underscoring the role of oronasal secretions in the spread of PCV3 within a cohort [20]. The presence of virus in feces and the environment further supports the potential for indirect transmission via contaminated bedding, feeding equipment, and transport vehicles [14].

The detection of PCV3 in serum samples from healthy and clinically affected pigs indicates that viremic animals are a significant source of viral dissemination [14, 18]. Retrospective studies have shown that PCV3 was circulating in the US swine industry as early as 2000, with a farm prevalence of 47%, and in China as early as 1996, establishing its endemic nature long before its formal discovery [3, 8]. This historical presence demonstrates a sustained, low-level circulation that primarily results in subclinical infections, a characteristic that complicates detection and control efforts [2, 10]. Subclinically infected pigs, which may harbor the virus without overt clinical signs, represent a silent reservoir that can perpetuate transmission chains within a herd and between farms through animal movement.

Vertical Transmission and Implications for Breeding Herd Biosecurity

The evidence for vertical transmission of PCV3 is compelling and is directly linked to its association with reproductive disease, including mummified fetuses, stillbirths, and weak neonates [2, 20]. The detection of PCV3 in testicular fluid with high frequency suggests that the virus can be shed in semen, potentially infecting sows at the time of artificial insemination or natural service [20]. The demonstration of PCV3 in fetal tissues and its association with reproductive failure confirms transplacental transmission [2]. This vertical route is a critical concern for biosecurity because it introduces the virus into a naïve breeding herd via infected semen or through the introduction of infected replacement gilts that were exposed in utero. The high prevalence of PCV3 in adult and sow farms, as observed in US diagnostic data, reinforces the significance of the breeding herd as a key epidemiological unit [10]. The World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization of the United Nations (FAO) recognize reproductive failure as a major economic driver for intervention in swine diseases, and the vertical transmission of PCV3 directly contributes to this burden. Biosecurity protocols must therefore include rigorous screening of semen and replacement breeding stock to prevent the entry of PCV3 into negative herds.

Non-Porcine Reservoir Hosts: Cattle, Mice, and Beyond

A paradigm-shifting aspect of PCV3 epidemiology is its detection in non-porcine species, which challenges the notion of strict host restriction and introduces a complex, multi-species transmission ecology. The most extensively studied non-porcine reservoir is cattle. In Shandong province, China, a seroprevalence investigation revealed PCV3 DNA in 34.7% of bovine samples [1]. A retrospective study of clinically healthy cattle in the same region from 2011 to 2018 reported a 28.95% positivity rate over eight years, with the sequenced strains all belonging to the PCV3b genotype [18]. These infected cattle exhibited no clinical symptoms, yet their role as a competent reservoir is profound. The authors explicitly stated that such cattle "could be a reservoir for the virus and probably transferred them back to pigs" [18]. This finding is of immense biosecurity concern, particularly on mixed-species farms or in regions where pigs and cattle are raised in close proximity. The detection of PCV3 in cattle with high sequence identity to porcine strains (>98%) confirms the ability of the virus to replicate or at least persist in bovine hosts, creating a potential spillback cycle [1]. Biosecurity measures must therefore extend beyond single-species thinking and consider the risk presented by other livestock present on the farm or in the surrounding environment.

Beyond cattle, the virus has been detected in commercially sourced laboratory mice (Mus musculus), with one study finding that all 20 serum samples from Balb/C and ICR mice were positive for PCV3 DNA, and complete genome sequences shared 97.9-98.8% identity with porcine strains [7]. The presence of PCV3 in mice is a dual concern. First, it identifies rodents as a potential mechanical or biological vector that can introduce and maintain the virus within a swine facility, making rodent control a critical biosecurity component. Second, it raises the possibility of using mice as an experimental model for PCV3, but more importantly, it demonstrates that the host range is broad and likely includes other synanthropic or wild species. The detection of PCV3 in wild boar, with infection risk often higher than in commercial pigs, further expands the reservoir network [6, 23]. Wild boar populations serve as a sylvatic reservoir that can maintain the virus independently of domestic swine and transmit it back to commercial farms through direct contact or environmental contamination, representing a persistent threat to regional biosecurity efforts [6].

The Role of Wild Boar and Backyard Production Systems

The epidemiology of PCV3 is not uniform across production systems. A pivotal study in Northern Italy demonstrated a "higher infection risk in wild boars and rural pigs compared to the commercial ones" [6]. Phylodynamic analysis confirmed a preferential viral flow from these wild and rural populations to commercial pigs, and a significant flow from wild to rural animals [6]. This indicates that non-commercial systems, including small-scale backyard farms and feral wild boar, are not just passive recipients of the virus but are active drivers of its maintenance and dissemination. These populations typically have lower biosecurity standards, limited health monitoring, and higher interaction with each other, creating a high-risk interface. The circulation of a highly divergent PCV3 clade in Italian rural pigs and wild boars, distinct from those in commercial herds, suggests independent evolutionary trajectories and underscores the danger of these reservoirs [6]. Similarly, studies in China have found PCV3 in Tibetan pigs and wild boar, highlighting the widespread nature of the infection in geographically isolated populations [15, 23]. For global biosecurity, these findings imply that regional control programs must include strategies for managing feral swine populations and providing support and education for smallholder farms to minimize the risk of spillover into the high-value commercial sector.

Implications for Comprehensive Biosecurity Strategies

The cumulative evidence on PCV3 transmission dynamics and reservoir hosts necessitates a fundamental shift in biosecurity thinking. It is no longer sufficient to focus exclusively on preventing direct pig-to-pig contact. A robust biosecurity plan must incorporate the following multi-layered elements:

1. Multi-Species Risk Assessment: Given the confirmed presence of PCV3 in cattle and mice, and its high prevalence in wild boar, biosecurity plans must explicitly assess and mitigate the risk of transmission from these species [1, 6, 7, 18]. This includes strict physical separation between swine and other livestock, rigorous rodent control programs, and the construction of secure perimeter fences to prevent contact with wild boar.
2. Semen and Genetic Material Screening: The high viral load in testicular fluid dictates that artificial insemination centers must implement routine, highly sensitive PCR screening (e.g., TaqMan-qPCR) for PCV3 to prevent the introduction of the virus into naïve sow herds [20].
3. Surveillance in Subclinical Populations: The high prevalence of subclinical infections in grower-finisher herds and healthy cattle requires active surveillance using oral fluids or pooled serum samples rather than relying solely on clinical observation [10, 14, 38]. Surveillance strategies should be informed by the understanding that PCV3 detection is more frequent in adult/sow farms [10].
4. Monitoring at the Wildlife-Livestock Interface: The demonstrated viral flow from wild boar and rural farms to intensive operations mandates that biosecurity must extend beyond the farm gate [6]. This could include participating in regional wild boar monitoring initiatives and ensuring that personnel and equipment from hunting or rural environments do not inadvertently bring the virus into commercial facilities.
5. Vaccination and Immunoprophylaxis: While currently no PCV3-specific commercial vaccine is widely available, the development of effective vaccines is a critical priority for long-term control. The use of immunomodulators, such as PigStim-V, has shown promise in enhancing the effectiveness of vaccination against PCV2, and similar approaches may be applicable to PCV3 in the future [37]. Vaccination strategies will need to account for the genetic diversity of circulating strains, including the dominant PCV3a, PCV3b, and PCV3c genotypes [10, 14, 15].

In summary, PCV3 is a highly prevalent, multi-host pathogen with a stable but evolving genome that has been circulating for decades before its discovery. Its transmission is sustained through both horizontal and vertical routes, and its ability to infect cattle, mice, and wild boar creates complex reservoir networks that can perpetuate and reintroduce the virus into domestic swine populations. Effective biosecurity requires a departure from single-species management towards an integrated, ecosystem-based approach that acknowledges the interconnectedness of domestic, wild, and peridomestic animal populations.

Genetic Diversity and Evolution of Porcine Circovirus 3: Capsid Protein Variability and Phylodynamics

The genetic landscape of Porcine Circovirus 3 (PCV3) presents a paradox that has fascinated and confounded veterinary virologists since its initial identification in 2016. Unlike its notorious relative, PCV2, which exhibits a relatively brisk evolutionary pace and pronounced genotypic diversification, PCV3 demonstrates a remarkable degree of genetic stasis across both temporal and spatial scales. Yet, beneath this veneer of stability lies a nuanced tapestry of capsid protein variability, selective pressure dynamics, and phylogeographic structuring that holds profound implications for viral pathogenesis, immune evasion, and the development of effective control strategies. This section dissects the molecular underpinnings of PCV3's genetic diversity, with a particular focus on the capsid (Cap) protein, the primary antigenic determinant and the principal target of host immune responses, and explores the phylodynamic forces that have shaped the global distribution of its genotypes.

Genotypic Classification and Capsid-Based Phylogenetic Frameworks

The classification of PCV3 into distinct genotypes has been a subject of iterative refinement, driven by an ever-expanding repository of complete genome and open reading frame 2 (ORF2) sequences. Early phylogenetic analyses, based largely on complete genome sequences and the 645-nucleotide ORF2 gene, established a tripartite genotype structure comprising PCV3a, PCV3b, and PCV3c [2, 9, 14]. This framework was initially proposed using a threshold of approximately 97-98% nucleotide identity in the ORF2 gene [1, 8]. However, the simple three-clade model proved insufficient to capture the full extent of genetic heterogeneity, particularly as sampling expanded from geographically disparate regions and across a broader temporal arc.

A landmark study by Chung et al. (2020) [16] addressed this limitation by performing maximum-likelihood mapping on 303 PCV3 sequences, demonstrating that a concatenated analysis of the replicase, ORF3, and capsid protein-coding genes provided the most robust support for clade differentiation. This approach resolved three major genogroups (1, 2, and 3) and further subdivided genogroup 3 into eight distinct subtypes (3a through 3h) [16]. This level of resolution was essential for discriminating strains that clustered ambiguously within the original PCV3a/b/c scheme. For instance, Korean strains IH_Korea_2017 and N62_Korea_2018 were assigned to genogroup 3 subtype a, while SJ_Korea_2017 fell into subtype g, and N5, N10, and N13 into subtype f [16]. These findings underscore the fact that the genetic diversity of PCV3, while constrained in overall magnitude, is structured into discrete lineages with distinct phylogeographic signatures.

Despite this complexity, the majority of global epidemiological surveys continue to rely on the PCV3a/PCV3b/PCV3c framework due to its simplicity and compatibility with the bulk of publicly available data. A persistent challenge, however, is the lack of universally accepted signature amino acid motifs that unequivocally define each genotype. Geng et al. (2019) [14] provided a critical insight by examining four putative signature residues within the capsid protein, at positions 24, 27, 77, and 150. They found that the PCV3a group exhibited a highly conserved pattern of valine (V), lysine (K), serine (S), and isoleucine (I) at these positions (the VKSI motif), present in 95% of strains. In stark contrast, PCV3b and PCV3c strains lacked such a consistent signature pattern, displaying considerable variability at these same residues [14]. This observation suggests that the capsid protein of PCV3a may be under stronger purifying selection to maintain a specific structural conformation, while PCV3b and PCV3c may represent more permissive or transitional lineages.

Spatiotemporal Dynamics of Capsid Protein Amino Acid Substitutions

The capsid protein of PCV3, comprising 214 amino acids, is the central nexus of genetic variability and the primary determinant of antigenic diversity. While the overall amino acid identity among PCV3 strains remains exceptionally high, typically above 97% [9, 13, 15], specific residues exhibit non-synonymous substitutions that recur across independent lineages and geographical locations, strongly suggesting adaptive significance.

One of the most extensively characterized mutations is the A24V substitution (alanine to valine at position 24 of the capsid). This mutation has been identified as a signature of diversifying selection in multiple independent studies. Kroeger et al. (2025) [3], in a retrospective analysis of US grower-finisher herds from 2000 to 2012, demonstrated that the A24V mutation was common across all PCV3 subtypes identified in their study. Notably, this mutation was frequently paired with R27K (arginine to lysine at position 27) [3]. The spatial proximity of these two residues within the folded capsid protein is critical; they reside within a region predicted to form an alpha-helix in early sequences, but molecular modeling revealed that the structural folding of amino acids 24 and 27 shifted from an alpha-helix to a coiled conformation in sequences from 2012 [3]. This structural transition could have profound consequences for capsid assembly, stability, or the presentation of conformational epitopes to the host immune system.

The functional importance of the A24V and R27K mutations is further supported by their recurrent detection in independent cohorts. Zhang et al. (2020) [13] identified V24A and K27R (the reciprocal mutations) when comparing a PCV3a strain from diarrheic piglets in Jiangxi, China, with PCV3b reference strains. Yang et al. (2022) [12] documented the presence of both A24V and R27K in PCV3 strains circulating in Southwest China, and notably, these mutations were located within predicted antibody recognition domains, leading the authors to hypothesize a role in immune evasion. The convergence of these mutations across North American, Asian, and European strains points to a conserved adaptive pathway, likely driven by host immune pressure.

Beyond positions 24 and 27, additional residues exhibit compelling patterns of variability. The I150L mutation (isoleucine to leucine at position 150) was identified as a signature of diversifying selection in US strains from 2006 [3] and was also common within the PCV3a2 subtype [3]. The F104Y mutation (phenylalanine to tyrosine at position 104) is of particular interest because it lies within a predicted T-cell epitope, and this substitution was present in sequences belonging to the PCV3c, PCV3b, and PCV3a3 subtypes [3]. The presence of a mutation within a potentially immunodominant region raises the possibility that this substitution represents an escape variant, allowing the virus to circumvent cellular immune responses.

A more expansive analysis conducted by Tai et al. (2026) [5] on 34 PCV3 strains from Hunan Province, China, identified twelve distinct amino acid substitution sites within the capsid protein. Crucially, ten of these variation sites were located within predicted B-cell linear epitopes [5]. This finding is particularly significant because it indicates that the regions of the capsid most accessible to the humoral immune system are also the most variable. The co-localization of amino acid substitutions and B-cell epitopes provides a mechanistic basis for antigenic drift in PCV3, albeit at a slower pace than observed in RNA viruses. The epitope prediction analysis by Yang et al. (2024) [39] in Xinjiang further corroborated this, showing that antigenic epitopes predicted by both IEDB and ElliPro contained variable residues.

Another important mutation, D124Y (aspartic acid to tyrosine at position 124), was uniquely identified in bovine-origin PCV3 strains from Shandong, China, suggesting a potential host-species adaptation [1]. This mutation was not prevalent in porcine strains, indicating that cross-species transmission events may impose selective pressures that drive specific amino acid changes.

Selection Pressure Analysis and Evolutionary Rate Estimation

The evolutionary dynamics of PCV3 are governed by a complex interplay of mutation, selection, and genetic drift. Quantitative estimates of the substitution rate have consistently placed PCV3 among the slowest-evolving single-stranded DNA viruses. Kroeger et al. (2025) [3] estimated the evolutionary rate of PCV3 at approximately 1.0 × 10⁻⁵ substitutions per site per year, a value that is an order of magnitude lower than that of PCV2 and comparable to that of some plant circoviruses. This slow rate is likely a consequence of the error-correcting capacity of host cellular DNA polymerases, which are hijacked for viral replication, resulting in a lower mutation rate compared to the error-prone RNA-dependent RNA polymerases employed by RNA viruses.

Selection pressure analyses, using the ratio of non-synonymous (dN) to synonymous (dS) substitutions, have painted a more complex picture. Diversifying (positive) selection has been detected at specific codons, particularly at positions 24 and 150 in US strains from 2006, and at positions 24 and 27 in strains from 2012 [3]. The dN/dS ratios at these sites significantly exceeded 1, indicating that non-synonymous changes were being actively favored rather than purged by purifying selection. This pattern is consistent with an arms race between the virus and the host immune system, where amino acid changes confer a fitness advantage by enabling immune evasion.

However, this positive selection is highly localized. The vast majority of the capsid protein, and indeed the entire PCV3 genome, is under strong purifying (negative) selection, which maintains the structural and functional integrity of essential proteins. The overall genomic stability of PCV3, reflected in nucleotide identities exceeding 97-98% among strains collected decades apart, is a testament to the predominance of purifying selection [8, 9, 12, 40]. Sun et al. (2018) [8] provided a striking demonstration of this stability by detecting PCV3 DNA in porcine samples collected in China as early as 1996, and showing that those archival strains shared 97.1-99.4% nucleotide identity with contemporary reference strains. This extraordinary conservation over a 20-year period reinforces the notion that the fundamental capsid structure is highly constrained.

Phylodynamic Patterns: Global Distribution, Temporal Origins, and Viral Flow

The phylodynamic analysis of PCV3 has revealed a virus that is globally distributed, yet with a population structure that reflects both historical emergence and contemporary transmission networks. Current evidence strongly supports the hypothesis that PCV3 has been circulating in swine populations for decades prior to its formal discovery in 2016. Retrospective studies have traced the virus back to 1996 in China [8], 2000 in the United States [3], 2012 in Zhejiang, China (based on seropositivity) [14], and prior to 2009 in the United States [8]. This widespread historical presence suggests that PCV3 is not a newly emerged pathogen but rather a long-established virus that was only recently discovered through the application of advanced molecular diagnostic tools, particularly metagenomic next-generation sequencing.

The phylogeographic structuring of PCV3 genotypes exhibits distinct patterns. In North America, the PCV3a genotype has been overwhelmingly dominant. Kroeger et al. (2025) [3] found that 12 of 13 complete genome sequences from US herds (2000-2012) clustered with the PCV3a reference strain, with only one sequence belonging to PCV3c. Similarly, Gainor et al. (2023) [4] reported that all 11 complete genomes from the Dominican Republic (the first report from the Caribbean region) were assigned to PCV3a. In Asia, a more complex and temporally dynamic distribution has emerged. Early studies in China (2018-2022) documented a roughly equal prevalence of PCV3a and PCV3b [9, 15]. However, more recent surveillance in Hunan Province (2021-2024) revealed a dramatic shift, with PCV3c becoming the predominant genotype (67.6%), followed by PCV3a (32.4%), and a complete absence of PCV3b [5]. This temporal replacement of genotypes suggests that PCV3c may possess a selective advantage in certain ecological or immunological contexts, or that it represents a lineage that has recently expanded its geographic range.

The role of non-commercial pig populations and wildlife in PCV3 phylodynamics has been a topic of intense investigation. Franzo et al. (2023) [6] conducted a landmark study in Northern Italy, comparing PCV3 occurrence in commercial pigs, rural (backyard) pigs, and wild boar. Their phylodynamic analysis revealed a significantly larger viral population size in wild and rural populations, and more importantly, estimated a preferential viral flow from these populations to commercial pigs. This finding is critical for understanding the epidemiology of PCV3: it suggests that the virus is maintained in wild boar and backyard pig populations, which act as a reservoir, and that spillover events into intensive farming operations are a recurring phenomenon. The study also identified a highly divergent clade circulating exclusively in Italian rural pigs and wild boar [6], indicating that these populations harbor unique genetic diversity not found in commercial herds. The detection of PCV3 in other species, such as cattle (28.95% prevalence in Shandong, China) [18] and commercially sourced laboratory mice (100% prevalence in one study) [7], further expands the potential reservoir host range and introduces the possibility of cross-species transmission events that could influence viral evolution.

Structural and Immunological Implications of Capsid Variability

The three-dimensional structure of the PCV3 capsid protein, inferred through homology modeling and molecular dynamics simulations, provides a structural context for understanding the functional consequences of observed amino acid variability. The key mutations at positions 24 and 27, as noted, are located in a region that transitions from an alpha-helix to a coil [3]. This region likely corresponds to a surface-exposed loop or domain involved in receptor binding, antibody recognition, or capsid assembly. The A24V and R27K changes alter both the hydrophobicity and the charge of this region, potentially affecting interactions with host cell receptors or neutralizing antibodies.

The identification of a conserved linear B-cell epitope, ³⁷DYYDKK⁴², within the first β-sheet of the capsid, by Li et al. (2025) [11] is a significant advance. This epitope exhibited 99.35% conservation among 1,247 PCV3 sequences analyzed, indicating that it is under strong purifying selection, likely because it is essential for capsid structural integrity. Residues ³⁹Y and ⁴²K were identified as critical for monoclonal antibody binding [11]. The high conservation of this epitope makes it an attractive target for diagnostic assay development (as demonstrated by the DAS-ELISA) and potentially for vaccine design.

Conversely, the variable epitopes identified by Tai et al. (2026) [5] and the predicted T-cell epitope containing F104Y [3] represent regions of the capsid that are both exposed to the immune system and permissive to variation. This duality suggests that the virus is engaging in an evolutionary balancing act: it must maintain essential structural features for viability while simultaneously altering surface-exposed residues to evade host immune responses. The relatively slow pace of this antigenic drift, compared to viruses like influenza, means that PCV3 vaccines, when developed, may require less frequent updating, but the potential for gradual erosion of vaccine efficacy over a period of years or decades should not be discounted.

Concluding Remarks on Diversity and Evolution

In summary, the genetic diversity of PCV3 is characterized by an overarching stability punctuated by localized, adaptive evolution at key positions in the capsid protein. The virus exhibits a tripartite genotype structure (PCV3a, PCV3b, PCV3c) that can be further resolved into multiple subtypes, but the overall nucleotide and amino acid identity among strains remains exceptionally high. The slow evolutionary rate (~

References

[1] Wang W, Sun W, Cao L, Zheng M, Zhu Y, Li W, et al.. An epidemiological investigation of porcine circovirus 3 infection in cattle in Shandong province, China. BMC Veterinary Research. 2019. DOI: https://doi.org/10.1186/s12917-019-1793-0

[2] Cobos À, Sibila M, Segalés J. Review of porcine circovirus 3–associated lesions in swine: Challenges and advances in diagnostics. Veterinary Pathology-Supplement. 2025. DOI: https://doi.org/10.1177/03009858251347522

[3] Kroeger M, Stott C, Shen H, Li G, Main R, Bush E, et al.. Epidemiological and molecular retrospective analysis of porcine circovirus 3 in the US grower-finisher herd.. Infection, Genetics and Evolution. 2025. DOI: https://doi.org/10.1016/j.meegid.2025.105819

[4] Gainor K, Fortuna YC, Alakkaparambil AS, González W, Malik Y, Ghosh S. Detection and Complete Genomic Analysis of Porcine circovirus 3 (PCV3) in Diarrheic Pigs from the Dominican Republic: First Report on PCV3 from the Caribbean Region. Pathogens. 2023. DOI: https://doi.org/10.3390/pathogens12020250

[5] Tai Y, Tang X, Fan J, Liu K, Pan W, Sun G, et al.. Molecular Epidemiological Investigation and Genetic Evolution Analysis of Porcine Circovirus 3 in Hunan Province, China, from 2021 to 2024. Viruses. 2026. DOI: https://doi.org/10.3390/v18020159

[6] Franzo G, Faustini G, Legnardi M, Berto G, Maso MD, Genna V, et al.. Wilder than intense: higher frequency, variability, and viral flows of porcine circovirus 3 in wild boars and rural farms compared to intensive ones in northern Italy. Frontiers in Microbiology. 2023. DOI: https://doi.org/10.3389/fmicb.2023.1234393

[7] Jiang S, Zhou N, Li Y, An J, Chang T. Detection and sequencing of porcine circovirus 3 in commercially sourced laboratory mice. Veterinary Medicine and Science. 2019. DOI: https://doi.org/10.1002/vms3.144

[8] Sun J, Wei L, Lu Z, Mi S, Bao F, Guo H, et al.. Retrospective study of porcine circovirus 3 infection in China. Transboundary and Emerging Diseases. 2018. DOI: https://doi.org/10.1111/tbed.12853

[9] Chen D, Huang Y, Guo Y, Wang L, Zhang Y, Zhou L, et al.. Prevalence and Evolution Analysis of Porcine Circovirus 3 in China from 2018 to 2022. Animals. 2022. DOI: https://doi.org/10.3390/ani12121588

[10] Cezar G, Magalhães E, Rupasinghe K, Chandra S, Silva GS, Almeida M, et al.. Using diagnostic data from veterinary diagnostic laboratories to unravel macroepidemiological aspects of porcine circoviruses 2 and 3 in the United States from 2002–2023. PLoS ONE. 2024. DOI: https://doi.org/10.1371/journal.pone.0311807

[11] Li Z, Zhao J, Tian A, Wu H, Chen H, Song Y. Development of a Highly Specific Monoclonal Antibody-Based Sandwich ELISA for Rapid Detection of Porcine Circovirus Type 3. Viruses. 2025. DOI: https://doi.org/10.3390/v17101340

[12] Yang Y, Xu T, Wen J, Yang L, Lai S, Sun X, et al.. Prevalence and phylogenetic analysis of porcine circovirus type 2 (PCV2) and type 3 (PCV3) in the Southwest of China during 2020–2022. Frontiers in Veterinary Science. 2022. DOI: https://doi.org/10.3389/fvets.2022.1042792

[13] Zhang F, Yuan W, Li Z, Zhang Y, Zeng X, Zhao M, et al.. Porcine Circovirus Type 3 in Pig Farms Experiencing Diarrhea in Jiangxi, China: Prevalence, Genome Sequence and Pathogenicity. Animals. 2020. DOI: https://doi.org/10.3390/ani10122324

[14] Geng S, Luo H, Liu Y, Chen C, Xu W, Chen Y, et al.. Prevalence of porcine circovirus type 3 in pigs in the southeastern Chinese province of Zhejiang. BMC Veterinary Research. 2019. DOI: https://doi.org/10.1186/s12917-019-1977-7

[15] Pan Y, Qiu S, Chen R, Zhang T, Liang L, Wang M, et al.. Molecular detection and phylogenetic analysis of porcine circovirus type 3 in Tibetan pigs on the Qinghai-Tibet Plateau of China. Virology Journal. 2022. DOI: https://doi.org/10.1186/s12985-022-01792-4

[16] Chung H, Nguyen V, Park Y, Park B. Genotyping of PCV3 based on reassembled viral gene sequences. Veterinary Medicine and Science. 2020. DOI: https://doi.org/10.1002/vms3.374

[17] Zhang Y, Zhang X, Cheng A, Wang M, Yin Z, Huang J, et al.. Apoptosis Triggered by ORF3 Proteins of the Circoviridae Family. Frontiers in Cellular and Infection Microbiology. 2021. DOI: https://doi.org/10.3389/fcimb.2020.609071

[18] Li Y, Ma Z, Liu M, Cao L, Zhang J, Jiao Q, et al.. Porcine circovirus 3 in cattle in Shandong province of China: A retrospective study from 2011 to 2018.. Veterinary Microbiology. 2020. DOI: https://doi.org/10.1016/j.vetmic.2020.108824

[19] Chang'a J, Bitanyi S, Kamigwe A, Magidanga B, Guo S, Makoroma P, et al.. Molecular characterization of porcine circovirus-2 and -3 in pigs in Tanzania. Journal of Veterinary Medical Science. 2023. DOI: https://doi.org/10.1292/jvms.23-0031

[20] Hu Z, Lai R, Xu W, Guan R, Li M, Zhang Z, et al.. Development of a TaqMan-based quantitative real-time PCR for the detection of Porcine circovirus type 3. Frontiers in Animal Science. 2025. DOI: https://doi.org/10.3389/fanim.2025.1603264

[21] Xu T, Chen L, Huang B, Zhu L, Sun X, Lai S, et al.. The first dog-origin porcine circovirus type 4 complete genomic sequence have high homology with that of pig-derived strains. Frontiers in Microbiology. 2023. DOI: https://doi.org/10.3389/fmicb.2023.1121177

[22] Zhang L, Wang T, Fu P, Zhao Y, Li H, Wang D, et al.. First Molecular Detection and Genetic Analysis of a Novel Porcine Circovirus (Porcine Circovirus 4) in Dogs in the World. Microbiology spectrum. 2023. DOI: https://doi.org/10.1128/spectrum.04333-22

[23] Hu X, Chen Z, Li Y, Ding Z, Zeng Q, Wan T, et al.. Detection of Porcine Circovirus 1/2/3 and Genetic Analysis of Porcine Circovirus 2 in Wild Boar from Jiangxi Province of China. Animals. 2022. DOI: https://doi.org/10.3390/ani12162021

[24] Zou J, Liu H, Chen J, Zhang J, Li X, Long Y, et al.. Development of a TaqMan-Probe-Based Multiplex Real-Time PCR for the Simultaneous Detection of Porcine Circovirus 2, 3, and 4 in East China from 2020 to 2022. Veterinary Sciences. 2022. DOI: https://doi.org/10.3390/vetsci10010029

[25] Chen X, Zhang J, Cui H, Zheng L, Ding X, Chen H, et al.. PfAgo-mediated a rapid and visual detection assay for porcine circovirus type 3 based on recombinase-aided amplification.. Analytica Chimica Acta. 2026. DOI: https://doi.org/10.1016/j.aca.2026.345298

[26] Zhou L, Zhou H, Fan Y, Wang J, Zhang R, Guo Z, et al.. Metagenomics to Identify Viral Communities Associated with Porcine Respiratory Disease Complex in Tibetan Pigs in the Tibetan Plateau, China. Pathogens. 2024. DOI: https://doi.org/10.3390/pathogens13050404

[27] Kubacki J, Fraefel C, Bachofen C. Implementation of next-generation sequencing for virus identification in veterinary diagnostic laboratories. Journal of Veterinary Diagnostic Investigation. 2020. DOI: https://doi.org/10.1177/1040638720982630

[28] Sun X, Zhang Q, Shan H, Cao Z, Huang J. Genome characteristics of atypical porcine pestivirus from abortion cases in Shandong Province, China. Virology Journal. 2023. DOI: https://doi.org/10.1186/s12985-023-02247-0

[29] Sun R, Liu H, Sun S, Wang Y, Shan Y, Li X, et al.. Development of a duplex real-time recombinase aided amplification assay for the simultaneous and rapid detection of PCV3 and PCV4. Virology Journal. 2025. DOI: https://doi.org/10.1186/s12985-025-02625-w

[30] Pfankuche V, Bodewes R, Hahn K, Puff C, Beineke A, Habierski A, et al.. Porcine Bocavirus Infection Associated with Encephalomyelitis in a Pig, Germany. Emerging Infectious Diseases. 2016. DOI: https://doi.org/10.3201/eid2207.152049

[31] Dawson H, Chen C, Gaynor BJ, Shao J, Urban J. The porcine translational research database: a manually curated, genomics and proteomics-based research resource. BMC Genomics. 2017. DOI: https://doi.org/10.1186/s12864-017-4009-7

[32] Manessis G, Mourouzis C, Griol A, Zurita-Herranz D, Peransi S, Sanchez C, et al.. Integration of Microfluidics, Photonic Integrated Circuits and Data Acquisition and Analysis Methods in a Single Platform for the Detection of Swine Viral Diseases. Animals. 2021. DOI: https://doi.org/10.3390/ani11113193

[33] Khan AS, Ng SHS, Vandeputte OM, AlJanahi A, Deyati A, Cassart J, et al.. A Multicenter Study To Evaluate the Performance of High-Throughput Sequencing for Virus Detection. Msphere. 2017. DOI: https://doi.org/10.1128/mSphere.00307-17

[34] Mikhaleva TV, Konnova SS. Prevention of respiratory diseases of pigs of viral-bacterial etiology in conditions of import substitution. Veterinary Science Today. 2025. DOI: https://doi.org/10.29326/2304-196x-2025-14-1-32-39

[35] Visuthsak W, Woonwong Y, Thanantong N, Poolperm P, Boonsoongnern A, Ratanavanichrojn N, et al.. PCV3 in Thailand: Molecular epidemiology and relationship with PCV2.. Transboundary and Emerging Diseases. 2021. DOI: https://doi.org/10.1111/tbed.14294

[36] Sitthicharoenchai P, Derscheid R, Schwartz K, Macedo NR, Sahin O, Chen X, et al.. Cases of high mortality in cull sows and feeder pigs associated with Streptococcus equi subsp. zooepidemicus septicemia. Journal of Veterinary Diagnostic Investigation. 2020. DOI: https://doi.org/10.1177/1040638720927669

[37] Semenov V, Tyurin V, Kuznetsov A, Nikitin D, Gladkikh L, Stolbov EV. Ensuring veterinary well-being and productivity of pigs with an immunotropic drug. Legal regulation in veterinary medicine. 2023. DOI: https://doi.org/10.52419/issn2782-6252.2022.4.131

[38] Almeida MN, Zimmerman JJ, Wang C, Linhares D. Assessment of abattoir based monitoring of PRRSV using oral fluids.. Preventive Veterinary Medicine. 2018. DOI: https://doi.org/10.1016/j.prevetmed.2018.08.002

[39] Yang K, Wang Z, Wang X, Bi M, Hu S, Li K, et al.. Epidemiological investigation and analysis of the infection of porcine circovirus in Xinjiang. Virology Journal. 2024. DOI: https://doi.org/10.1186/s12985-024-02504-w

[40] Jia Y, Zhu Q, Xu T, Chen X, Li H, Ma M, et al.. Detection and genetic characteristics of porcine circovirus type 2 and 3 in Henan province of China.. Molecular and Cellular Probes. 2022. DOI: https://doi.org/10.1016/j.mcp.2022.101790